Comparison of the most important characteristics of diabetes and cancer

CharacteristicsDiabetes mellitusCancer
PrevalenceEpidemic prevalence with an ever-increasing incidence rateEpidemic prevalence with an ever-increasing incidence rate
Classification90–95% T2DM (lifestyle-related, mostly in older adults), 5–10% T1DM (probably heritable, juvenile-onset type)90–95% sporadic (lifestyle-related, in older adults > 50 years of age), 5–10% genetic (heritable type, in younger age)
General featureDestruction of pancreatic β-cells, decrease in islets massDevelopment of malignant cells, formation of neoplasm
DescriptionChronic lifelong metabolic disease with insulin resistance as a long-term preceding phase for T2DM (often latent)Chronic metabolic disease with a long latency period (about 10–20 years) before diagnosis of invasive cancer
Pathogenesis is closely associated with inflammationPathogenesis is closely associated with inflammation
Final stageMultiorgan complicationsDistal metastases
Pharmacological aims in target cellsPancreatic β-cells: oxidative stress (ROS), DNA damage, and apoptosisMalignant cells: oxidative stress (ROS), DNA damage, and apoptosis
Treatment optionsNo curative treatment options were still available. Dietary modification, oral hypoglycemics, and insulin (i.e., drugs lowering blood glucose level). No therapies discovered to prevent diabetic complicationsNo curative treatment options were still available. Surgery, chemotherapy, radiotherapy, and targeted therapy (i.e., strategies suppressing the primary tumors). No therapies discovered to prevent the formation of metastases
Importance of natural products in drug discoveryThe first-line used drug, metformin, was originally derived from French lilac. Acarbose isolated from Actinomycetes speciesMore than 60% of approved drugs are originally derived from different natural products, such as various plant extracts, marine organisms, and microorganisms

ROS: reactive oxygen species; T2DM: type 2 diabetes mellitus